by Integumen_1 | Jan 7, 2019 | Cellulac, Financials, Innovenn, Labskin, StoerForMen, Updates
Restructuring is Accelerating Growth into 2019 Trading Update The Company is pleased to announce the positive results of major restructuring and accelerated growth in product sales and contract test services at Labskin (Innovenn Limited, a wholly-owned subsidiary of...
by Integumen_1 | Dec 13, 2018 | Innovenn, Labskin
Labskin-On-A-Chip to monitor real-time skin related diseases and Labskin-AI data analysis to predict the best course of treatment Integumen is pleased to announce a cross-platform biophysics agreement with AI developer, Rinocloud Limited, in association with Cork...
by Integumen_1 | Nov 15, 2018 | Financials, Innovenn, Labskin, StoerForMen, Updates
Major Restructuring Causing Increased Growth Trading Update The Company is pleased to announce the increased growth in product sales and contract test services at Labskin (Innovenn Limited, a wholly-owned subsidiary of Integumen plc). With improved visibility ahead,...
by Integumen_1 | Sep 17, 2018 | Innovenn, Labskin
First laboratory-grown human-skin test service, to use artificial intelligence, to provide clinical validation for cosmetic, personal hygiene and skin care products. Labskin (Innovenn Ltd.), a wholly-owned subsidiary of Integumen plc., (AIM:SKIN) today announces that...
Recent Comments